Literature DB >> 3402521

Influence of renal function on the elimination of morphine and morphine glucuronides.

J Wolff1, D Bigler, C B Christensen, S N Rasmussen, H B Andersen, K H Tønnesen.   

Abstract

The influence of renal function, measured by 51Cr-EDTA clearance, on morphine and morphine glucuronide kinetics has been studied in 13 patients after a single i.v. injection of morphine. Unconjugated morphine and morphine glucuronides were measured by a sensitive, specific RIA after extraction from plasma. No significant correlation was found between total body clearance of unconjugated morphine and 51Cr-EDTA clearance. However, patients with renal insufficiency had impaired elimination of morphine glucuronides, and the apparent clearance was significantly correlated with the 51Cr-EDTA clearance (r = 0.94, p less than 0.001). A relatively long terminal elimination of half-life of morphine was found in all patients (mean +/- SD: 9.2 +/- 2.5 h), irrespective of glomerular function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3402521     DOI: 10.1007/bf00542435

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Morphine-6-glucuronide has high affinity for the opioid receptor.

Authors:  C B Christensen; L N Jørgensen
Journal:  Pharmacol Toxicol       Date:  1987-01

2.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

3.  Be aware of renal function when prescribing morphine.

Authors:  H McQuay; A Moore
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

4.  Kinetics of morphine in patients with renal failure.

Authors:  J Säwe; J O Svensson; I Odar-Cederlöf
Journal:  Lancet       Date:  1985-07-27       Impact factor: 79.321

5.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

6.  Sensitive and specific morphine radioimmunoassay with iodine label: pharmacokinetics of morphine in man after intravenous administration.

Authors:  R A Moore; D Baldwin; M C Allen; P J Watson; R E Bullingham; H J McQuay
Journal:  Ann Clin Biochem       Date:  1984-07       Impact factor: 2.057

7.  Urinary excretion of morphine and its metabolites in morphine-dependent subjects.

Authors:  S Y Yeh
Journal:  J Pharmacol Exp Ther       Date:  1975-01       Impact factor: 4.030

8.  Morphine kinetics during and after renal transplantation.

Authors:  A Moore; J Sear; D Baldwin; M Allen; A Hunniset; R Bullingham; H McQuay
Journal:  Clin Pharmacol Ther       Date:  1984-05       Impact factor: 6.875

Review 9.  High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.

Authors:  J Säwe
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

10.  Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure.

Authors:  A R Aitkenhead; M Vater; K Achola; C M Cooper; G Smith
Journal:  Br J Anaesth       Date:  1984-08       Impact factor: 9.166

View more
  12 in total

Review 1.  Implications of opioid analgesia for medically complicated patients.

Authors:  Howard Smith; Patricia Bruckenthal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

Review 2.  Opioid metabolism.

Authors:  Howard S Smith
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

3.  Respiratory depression with patient-controlled analgesia.

Authors:  A D Baxter
Journal:  Can J Anaesth       Date:  1994-02       Impact factor: 5.063

4.  The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.

Authors:  R W Milne; R L Nation; A A Somogyi; F Bochner; W M Griggs
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

5.  Comparative bioavailability of a morphine suppository given rectally and in a colostomy.

Authors:  J Højsted; K Rubeck-Petersen; H Rask; D Bigler; C Broen Christensen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration.

Authors:  G M Peterson; C T Randall; J Paterson
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  Pharmacodynamic Analysis of Morphine Time-to-Remedication Events in Infants and Young Children After Congenital Heart Surgery.

Authors:  Mohammed H Elkomy; David R Drover; Jeffery L Galinkin; Gregory B Hammer; Kristi L Glotzbach
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

8.  Decreased Morphine Clearance in Neonates With Hypoxic Ischemic Encephalopathy Receiving Hypothermia.

Authors:  Adam Frymoyer; Sonia L Bonifacio; David R Drover; Felice Su; Courtney J Wustoff; Krisa P Van Meurs
Journal:  J Clin Pharmacol       Date:  2016-06-26       Impact factor: 3.126

9.  Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart Surgery.

Authors:  Mohammed H Elkomy; David R Drover; Kristi L Glotzbach; Jeffery L Galinkin; Adam Frymoyer; Felice Su; Gregory B Hammer
Journal:  AAPS J       Date:  2015-09-09       Impact factor: 4.009

10.  Options for treating postherpetic neuralgia in the medically complicated patient.

Authors:  Patricia Bruckenthal; Robert L Barkin
Journal:  Ther Clin Risk Manag       Date:  2013-08-19       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.